Xenetic Biosciences earnings were -$2.7M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest XBIO earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$579.1k, up 13.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, XBIO reported annual earnings of -$2.7M, with -32.3% growth.
Xenetic Biosciences Earnings Reports & History FAQ
What were Xenetic Biosciences's earnings last quarter?
Xenetic Biosciences (NASDAQ: XBIO) reported Q4 2025 earnings per share (EPS) of -$0.22, up 67.65% year over year. Total XBIO earnings for the quarter were -$579.08 thousand. In the same quarter last year, Xenetic Biosciences's earnings per share (EPS) was -$0.68.
Is Xenetic Biosciences profitable or losing money?
As of the last Xenetic Biosciences earnings report, Xenetic Biosciences is currently losing money. Xenetic Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$2.68 million, a 32.31% decrease year over year.
What was XBIO's earnings growth in the past year?
As of Xenetic Biosciences's earnings date in Q2 2026, Xenetic Biosciences's earnings has grown year over year. XBIO earnings in the past year totalled -$2.68 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.